HUP0003354A3 - Use of anti-inflammatory steroids for the preparation of pharmaceutical compositions of chronic inflammatory intestinal diseases - Google Patents

Use of anti-inflammatory steroids for the preparation of pharmaceutical compositions of chronic inflammatory intestinal diseases

Info

Publication number
HUP0003354A3
HUP0003354A3 HU0003354A HUP0003354A HUP0003354A3 HU P0003354 A3 HUP0003354 A3 HU P0003354A3 HU 0003354 A HU0003354 A HU 0003354A HU P0003354 A HUP0003354 A HU P0003354A HU P0003354 A3 HUP0003354 A3 HU P0003354A3
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical compositions
inflammatory
intestinal diseases
steroids
Prior art date
Application number
HU0003354A
Other languages
Hungarian (hu)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HUP0003354A2 publication Critical patent/HUP0003354A2/en
Publication of HUP0003354A3 publication Critical patent/HUP0003354A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0003354A 1997-06-04 1998-06-02 Use of anti-inflammatory steroids for the preparation of pharmaceutical compositions of chronic inflammatory intestinal diseases HUP0003354A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201690 1997-06-04
PCT/EP1998/003473 WO1998055126A2 (en) 1997-06-04 1998-06-02 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases

Publications (2)

Publication Number Publication Date
HUP0003354A2 HUP0003354A2 (en) 2001-03-28
HUP0003354A3 true HUP0003354A3 (en) 2001-09-28

Family

ID=8228405

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003354A HUP0003354A3 (en) 1997-06-04 1998-06-02 Use of anti-inflammatory steroids for the preparation of pharmaceutical compositions of chronic inflammatory intestinal diseases

Country Status (12)

Country Link
EP (1) EP0984782A2 (en)
JP (1) JP2002502409A (en)
KR (1) KR20010013335A (en)
CN (1) CN1336824A (en)
AU (1) AU740005B2 (en)
BR (1) BR9809551A (en)
CA (1) CA2290775A1 (en)
HU (1) HUP0003354A3 (en)
NO (1) NO995936D0 (en)
PL (1) PL337458A1 (en)
TR (1) TR199902812T2 (en)
WO (1) WO1998055126A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335819B (en) * 2002-12-24 2011-01-11 Alcon Inc Use of oculosurface selective glucocorticoid in the treatment of dry eye

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947478A (en) * 1972-01-12 1976-03-30 Akzona Incorporated Alkylated 3,20-diketo-Δ4 -steroids of the pregnane series
GB1416427A (en) * 1972-01-12 1975-12-03 Akzo Nv Alkylated pregnanes and process for obtaining same
DE3064460D1 (en) * 1979-01-24 1983-09-08 Akzo Nv Novel alkylated pregnanes, processes for their preparation and pharmaceutical compositions containing same
FR2747680B1 (en) * 1996-04-18 1998-07-03 Roussel Uclaf NOVEL STEROIDS, THEIR APPLICATION AS MEDICAMENTS, THEIR PREPARATION PROCESS, THE INTERMEDIATES THEREOF AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
JP2002502409A (en) 2002-01-22
AU8625298A (en) 1998-12-21
NO995936L (en) 1999-12-03
BR9809551A (en) 2000-06-20
CA2290775A1 (en) 1998-12-10
WO1998055126A3 (en) 1999-03-11
AU740005B2 (en) 2001-10-25
EP0984782A2 (en) 2000-03-15
PL337458A1 (en) 2000-08-14
WO1998055126A2 (en) 1998-12-10
HUP0003354A2 (en) 2001-03-28
KR20010013335A (en) 2001-02-26
TR199902812T2 (en) 2000-06-21
NO995936D0 (en) 1999-12-03
CN1336824A (en) 2002-02-20

Similar Documents

Publication Publication Date Title
HUP0101693A3 (en) Use of steroidal sapogenins and their derivatives for producing pharmaceutical compositions for the treatment of alzheimeirs disease
AU4010395A (en) Compositions for increased bioavailability of orally delivered therapeutic agents
EP0759750A4 (en) Compositions for treatment of chronic inflammatory diseases
HUP0201872A2 (en) Steroid compounds and pharmaceutical compositions of the same
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
HUP0004071A3 (en) Pharmaceutical compositions comprising prostaglandin derivatives
HUP0000397A3 (en) The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation
EP0879824A4 (en) Triterpene derivatives and remedy for liver diseases
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
AU1354495A (en) Formulations for orally administered pharmaceutical agents
EP0889051A4 (en) Triterpene derivatives and remedies for liver diseases
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP9900309A3 (en) Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
HUP0003354A2 (en) Use of anti-inflammatory steroids for the preparation of pharmaceutical compositions of chronic inflammatory intestinal diseases
AU6961298A (en) Therapeutic compositions and diagnostic assays for diseases involving trbp
ZA983046B (en) 4-Halogenated steroids their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them
HUP9901969A3 (en) Use of n-mercaptoalkanoyl-cysteine derivatives for the preparation of pharmaceutical compositions traiting ischemia
GB2392915B (en) Pharmaceutical formulation of fluticasone propionate
AU4585893A (en) Remedy for inflammatory intestinal diseases
AU5296799A (en) Pharmaceutical compositions against autoimmune diseases
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
FI973277A0 (en) Pharmaceutical preparations for the inhibition of TNF
ITMI981741A0 (en) PHARMACEUTICAL FORMULATIONS OF BECLOMETASONE DIPROPINATE FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINAE MUCOSA
GB9725346D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease